TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 31.1 Cr.
- Current Price ₹ 41.5
- High / Low ₹ 79.5 / 35.0
- Stock P/E 9.86
- Book Value ₹ 50.6
- Dividend Yield 0.00 %
- ROCE 8.84 %
- ROE 8.70 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.82 times its book value
- Debtor days have improved from 145 to 99.5 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.57% over last 3 years.
- Earnings include an other income of Rs.4.78 Cr.
- Working capital days have increased from -70.7 days to 111 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 0.92 | 4.23 | 3.46 | 7.16 | 31.65 | 24.73 | |
1.22 | 0.43 | 0.50 | 0.72 | 0.35 | 1.26 | 1.67 | 4.27 | 5.78 | 9.71 | 32.01 | 25.64 | |
Operating Profit | -1.22 | -0.43 | -0.50 | -0.72 | -0.35 | -0.86 | -0.75 | -0.04 | -2.32 | -2.55 | -0.36 | -0.91 |
OPM % | -215.00% | -81.52% | -0.95% | -67.05% | -35.61% | -1.14% | -3.68% | |||||
0.05 | 0.02 | 0.06 | 0.22 | -0.39 | 0.04 | 1.15 | 1.23 | -1.56 | 0.23 | 0.82 | 4.78 | |
Interest | 0.00 | 0.00 | 0.00 | 0.05 | 0.01 | 0.12 | 0.01 | 0.01 | 0.01 | 0.27 | 0.15 | 0.59 |
Depreciation | 0.28 | 0.07 | 0.06 | 0.06 | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.19 | 0.07 | 0.16 |
Profit before tax | -1.45 | -0.48 | -0.50 | -0.61 | -0.75 | -0.94 | 0.38 | 1.16 | -3.93 | -2.78 | 0.24 | 3.12 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.52% | 0.00% | -0.72% | 16.67% | -0.96% |
-1.44 | -0.48 | -0.50 | -0.61 | -0.75 | -0.95 | 0.39 | 0.98 | -3.93 | -2.77 | 0.20 | 3.15 | |
EPS in Rs | -1.92 | -0.64 | -0.67 | -0.81 | -1.00 | -1.27 | 0.52 | 1.31 | -5.24 | -3.70 | 0.27 | 4.21 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 93% |
3 Years: | 93% |
TTM: | -22% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 52% |
3 Years: | 56% |
TTM: | 1475% |
Stock Price CAGR | |
---|---|
10 Years: | -3% |
5 Years: | 9% |
3 Years: | 14% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 0% |
3 Years: | 1% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 |
Reserves | -27.69 | -29.20 | -29.70 | -30.31 | 30.33 | 29.02 | 29.16 | 30.14 | 23.73 | 26.90 | 27.10 | 30.36 |
24.28 | 24.69 | 25.15 | 6.30 | 5.38 | 5.38 | 5.64 | 5.83 | 6.02 | 1.08 | 0.27 | 11.22 | |
7.26 | 7.28 | 7.29 | 26.73 | 25.74 | 31.35 | 27.23 | 29.14 | 30.19 | 37.04 | 54.92 | 34.08 | |
Total Liabilities | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 | 83.14 |
2.49 | 1.39 | 1.33 | 1.26 | 58.01 | 58.01 | 58.01 | 58.42 | 54.70 | 35.12 | 16.85 | 13.59 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.24 | 0.24 | 0.24 | 0.24 | 0.80 | 0.44 | 0.19 | 0.19 | 0.17 | 0.52 | 0.91 | 1.62 |
4.52 | 4.54 | 4.57 | 4.62 | 6.04 | 10.70 | 7.23 | 9.90 | 8.47 | 36.86 | 72.01 | 67.93 | |
Total Assets | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 | 83.14 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.31 | -0.40 | -0.43 | -0.72 | -4.39 | -1.63 | -0.56 | -0.11 | -2.79 | -9.56 | 3.74 | -10.79 | |
0.00 | 0.00 | 0.00 | 0.00 | 3.98 | -0.01 | -0.01 | -0.04 | 2.81 | 4.39 | -2.78 | 0.53 | |
0.32 | 0.41 | 0.47 | 0.83 | 0.15 | 5.32 | -3.14 | 0.18 | 0.20 | 4.99 | -0.94 | 10.37 | |
Net Cash Flow | 0.01 | 0.01 | 0.03 | 0.10 | -0.25 | 3.68 | -3.70 | 0.03 | 0.22 | -0.18 | 0.01 | 0.11 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.16 | 238.07 | 97.45 | 99.48 | |||||
Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.13 | 852.04 | 570.68 | |||||
Days Payable | 2,581.07 | 1,914.85 | 747.47 | 65.98 | 71.72 | 76.06 | 47.36 | |||||
Cash Conversion Cycle | 274.18 | -360.73 | -62.13 | 321.51 | 435.48 | 873.42 | 622.80 | |||||
Working Capital Days | -6,077.25 | -972.01 | -309.78 | -674.09 | -422.60 | 99.41 | 110.99 | |||||
ROCE % | -268.52% | -1.30% | -2.13% | 1.03% | 2.04% | -4.72% | -7.32% | 1.11% | 8.84% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Copies of Newspaper clippings regarding Audited Consolidated and Standalone Financial Results for the Quarter ended 31st March 2025 published on Friday, 30th May 2025 in …
-
Revised Outcome Of The Board Meeting After Inclusion Of The ''Declaration To The Effect That Auditors Report On Audited Financials Is With Unmodified Opinion''.
30 May - TCM Limited reports audited FY25 standalone and consolidated results with profit before tax Rs.311.52L and Rs.136.53L respectively.
-
Board Comments On SOP Fines Levied
29 May - TCM Limited fined Rs.2,360 by BSE for delayed shareholding pattern submission; fine paid and compliance assured.
-
Board Meeting Outcome for Outcome Of The Board Meeting And Consolidated & Standalone Audited Financial Statements For The Year Ended 31St March 2025
29 May - TCM Limited reports audited FY25 standalone and consolidated results with profit before tax Rs.311.52 lakhs standalone, Rs.136.53 lakhs consolidated.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual Secretarial Compliance Report for FY ended 31 Mar 2025; minor one-day filing delay with late fee paid.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants